Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,350 JPY | +1.28% | +2.47% | +34.67% |
31/01 | Japan's small cohort of listed firms led by women | RE |
2023 | Stella Chemifa Targeting Medium-Term Sales of 40 Billion Yen | MT |
Business Summary
Number of employees: 727
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
High Purity Chemicals
86.8
%
| 32,330 | 86.7 % | 30,707 | 86.8 % | -5.02% |
Transportation
12.7
%
| 4,676 | 12.5 % | 4,504 | 12.7 % | -3.68% |
Others
0.5
%
| 189 | 0.5 % | 170 | 0.5 % | -10.05% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
50.5
%
| 19,102 | 51.2 % | 17,857 | 50.5 % | -6.52% |
South Korea
17.6
%
| 5,547 | 14.9 % | 6,220 | 17.6 % | +12.13% |
Asia (Others)
15.8
%
| 4,555 | 12.2 % | 5,602 | 15.8 % | +22.99% |
China
6.5
%
| 4,886 | 13.1 % | 2,301 | 6.5 % | -52.91% |
North America
5.0
%
| 1,360 | 3.6 % | 1,777 | 5.0 % | +30.66% |
Europe
4.4
%
| 1,808 | 4.8 % | 1,572 | 4.4 % | -13.05% |
Others
0.1
%
| 36 | 0.1 % | 50 | 0.1 % | +38.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Aki Hashimoto
PSD | President | 50 | 01/12/01 |
Jun Takano
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/85/01 |
Takeshi Iijima
BRD | Director/Board Member | 57 | 01/91/01 |
Director/Board Member | 64 | 01/16/01 | |
Norio Ogata
BRD | Director/Board Member | 55 | 01/92/01 |
Masaaki Tsuchiya
BRD | Director/Board Member | 53 | 01/89/01 |
Kiyonori Saka
BRD | Director/Board Member | 65 | 01/82/01 |
Director/Board Member | 74 | 01/77/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Aki Hashimoto
PSD | President | 50 | 01/12/01 |
Director/Board Member | 74 | 01/77/01 | |
Jun Takano
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/85/01 |
Kiyonori Saka
BRD | Director/Board Member | 65 | 01/82/01 |
Norio Ogata
BRD | Director/Board Member | 55 | 01/92/01 |
Isao Okano
BRD | Director/Board Member | 82 | 01/08/01 |
Director/Board Member | 64 | 01/16/01 | |
Yusaku Nishimura
BRD | Director/Board Member | 54 | 01/12/01 |
Takeshi Iijima
BRD | Director/Board Member | 57 | 01/91/01 |
Shine Matsumura
BRD | Director/Board Member | 70 | 01/18/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 13,213,248 | 7,108,744 ( 53.80 %) | 1,185,297 ( 8.971 %) | 53.80 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,047,397 | 7.93% | 25,558,445 $ | |
STELLA PHARMA CORPORATION 36.67% | 11,450,000 | 36.67% | 21,755,458 $ |
Company contact information
Stella Chemifa Corp.
Meiji Yasuda Seimei Osaka Midosuji 4-1-1 Fushimi-machi
541-0044, Osaka
+81 6 4707 1511
http://www.stella-chemifa.co.jpSales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.67% | 329M | |
+3.08% | 103B | |
-10.06% | 60.12B | |
+72.86% | 48.78B | |
+17.31% | 39.05B | |
+3.82% | 32.14B | |
+13.58% | 20.44B | |
+13.81% | 16.97B | |
+11.47% | 14.26B | |
-0.10% | 13.66B |
- Stock Market
- Equities
- 4109 Stock
- Company Stella Chemifa Corporation